Chapter 14 Interactions between the Membrane-Cytoskeleton and CD44 during Lymphocyte Signal Transduction and Cell Adhesion
暂无分享,去创建一个
[1] H. Liao,et al. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. , 1995, Journal of immunology.
[2] L. Bourguignon,et al. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells , 1995, Journal of cellular physiology.
[3] A. Perschl,et al. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation , 1995, The Journal of experimental medicine.
[4] K. Oritani,et al. Glycosylation of CD44 negatively regulates its recognition of hyaluronan , 1995, The Journal of experimental medicine.
[5] L. Bourguignon,et al. Ryanodine Receptor-Ankyrin Interaction Regulates Internal Ca Release in Mouse T-lymphoma Cells (*) , 1995, The Journal of Biological Chemistry.
[6] C. Isacke,et al. Hyaluronan binding by CD44 is regulated by a phosphorylation‐independent mechanism , 1995, European journal of immunology.
[7] S. Jalkanen,et al. CD44v6 expression in non‐Hodgkin's lymphoma: An association with low histological grade and poor prognosis , 1995, The Journal of pathology.
[8] G. Dougherty,et al. To metastasize or not? Selection of CD44 splice sites , 1995, Nature Medicine.
[9] A. Droll,et al. Adhesive interactions between alternatively spliced CD44 isoforms , 1995, Journal of Biological Chemistry.
[10] L. Bourguignon,et al. Identification of the Ankyrin-binding Domain of the Mouse T-lymphoma Cell Inositol 1,4,5-Trisphosphate (IP3) Receptor and Its Role in the Regulation of IP3-mediated Internal Ca2+ Release (*) , 1995, The Journal of Biological Chemistry.
[11] H. Sorimachi,et al. A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan , 1995, The Journal of Biological Chemistry.
[12] S. Kumar,et al. The role of hyaluronan in tumour neovascularization (review) , 1995, International journal of cancer.
[13] V. Bennett,et al. AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. , 1995, The Journal of biological chemistry.
[14] J. Bell,et al. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon , 1995, The Journal of cell biology.
[15] I. Stamenkovic,et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor , 1995, The Journal of cell biology.
[16] I. Trowbridge,et al. Role of CD44 cytoplasmic domain in hyaluronan binding , 1995, European journal of immunology.
[17] E. Puré,et al. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain , 1995, The Journal of experimental medicine.
[18] L. Bourguignon,et al. New CD44 splice variants associated with human breast cancers , 1995, Journal of cellular physiology.
[19] C. Isacke,et al. The role of the cytoplasmic domain in regulating CD44 function. , 1994, Journal of cell science.
[20] L. Bourguignon,et al. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function , 1994, The Journal of cell biology.
[21] N. Sato,et al. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons , 1994, The Journal of cell biology.
[22] R. Savani,et al. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. , 1994, The EMBO journal.
[23] X. Chen,et al. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. , 1993, Journal of immunology.
[24] H. Liao,et al. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. , 1993, Journal of immunology.
[25] P. Herrlich,et al. CD44 splice variants: metastases meet lymphocytes. , 1993, Immunology today.
[26] I. Stamenkovic,et al. Identification of hyaluronic acid binding sites in the extracellular domain of CD44 , 1993, The Journal of cell biology.
[27] L. Bourguignon,et al. The involvement of ankyrin in the regulation of inositol 1,4,5-trisphosphate receptor-mediated internal Ca2+ release from Ca2+ storage vesicles in mouse T-lymphoma cells. , 1993, The Journal of biological chemistry.
[28] P. Herrlich,et al. Splicing choice from ten variant exons establishes CD44 variability. , 1993, Nucleic acids research.
[29] P. Herrlich,et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps , 1993, The Journal of cell biology.
[30] J. Bell,et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[31] K. Ishihara,et al. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition , 1992, The Journal of cell biology.
[32] L. Bourguignon,et al. The lymphoma transmembrane glycoprotein GP85 (CD44) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction. , 1992, The Journal of biological chemistry.
[33] D. Tarin,et al. Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.
[34] Y. Nishizuka. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.
[35] L. Bourguignon,et al. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin , 1992, Molecular and cellular biology.
[36] P. Herrlich,et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. , 1992, Science.
[37] V. Bennett,et al. Ankyrins. Adaptors between diverse plasma membrane proteins and the cytoplasm. , 1992, The Journal of biological chemistry.
[38] S. Jalkanen,et al. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin , 1992, The Journal of cell biology.
[39] Q. He,et al. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody , 1992, The Journal of experimental medicine.
[40] P. Herrlich,et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. , 1991, Cancer research.
[41] L. Bourguignon,et al. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. , 1991, The Journal of biological chemistry.
[42] V. Bennett,et al. Distinct ankyrin isoforms at neuron cell bodies and nodes of Ranvier resolved using erythrocyte ankyrin-deficient mice , 1991, The Journal of cell biology.
[43] D. Benos,et al. Amiloride-sensitive sodium channel is linked to the cytoskeleton in renal epithelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[44] L. Bourguignon,et al. Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. , 1991, The Journal of biological chemistry.
[45] S. Jalkanen,et al. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. , 1991, The Journal of clinical investigation.
[46] Martin Hofmann,et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.
[47] E. Turley,et al. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells , 1991, The Journal of cell biology.
[48] M. Amiot,et al. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.
[49] Frank McCormick,et al. The GTPase superfamily: conserved structure and molecular mechanism , 1991, Nature.
[50] M. Letarte,et al. Confirmation by peptide sequence and co-expression on various cell types of the identity of CD44 and P85 glycoprotein. , 1990, Molecular immunology.
[51] C. Meijer,et al. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). , 1990, Leukemia.
[52] K. Miyake,et al. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition , 1990, The Journal of experimental medicine.
[53] R. Schulte,et al. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. , 1990, Experimental cell research.
[54] J. August,et al. Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. , 1990, Journal of immunology.
[55] T. Hamaoka,et al. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long- term bone marrow cultures , 1990, The Journal of experimental medicine.
[56] M. Schmidt. Fatty acylation of proteins , 1989, Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes.
[57] M. Telen,et al. CD44--a molecule involved in leukocyte adherence and T-cell activation. , 1989, Immunology today.
[58] D. Goeddel,et al. Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. , 1989, Journal of immunology.
[59] J. Lingrel,et al. Characterization of the human Na,K-ATPase alpha 2 gene and identification of intragenic restriction fragment length polymorphisms. , 1989, The Journal of biological chemistry.
[60] S. Kumar,et al. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. , 1989, Experimental cell research.
[61] V. Bennett,et al. Mapping the ankyrin-binding site of the human erythrocyte anion exchanger. , 1989, The Journal of biological chemistry.
[62] L. Bourguignon,et al. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. , 1989, The Journal of biological chemistry.
[63] L. Picker,et al. A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins , 1989, Cell.
[64] M. Kashgarian,et al. Ankyrin links fodrin to the alpha subunit of Na,K-ATPase in Madin-Darby canine kidney cells and in intact renal tubule cells , 1989, The Journal of cell biology.
[65] G. Tarone,et al. Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor. , 1988, Experimental cell research.
[66] S. Jalkanen,et al. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. , 1988, Journal of immunology.
[67] William,et al. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. , 1988, The Journal of biological chemistry.
[68] L. Bourguignon,et al. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin , 1988, The Journal of cell biology.
[69] P. Comoglio,et al. The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity. , 1987, The Journal of biological chemistry.
[70] Nelson Wj,et al. Ankyrin binding to (Na+ + K+)ATPase and implications for the organization of membrane domains in polarized cells. , 1987 .
[71] J. R. de los Toyos,et al. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells , 1987, The Journal of cell biology.
[72] L. Bourguignon,et al. A lymphoma plasma membrane-associated protein with ankyrin-like properties , 1986, The Journal of cell biology.
[73] B. E. Lacy,et al. Characterization and identification of the hyaluronate binding site from membranes of SV-3T3 cells. , 1985, The Journal of biological chemistry.
[74] R. Schulte,et al. Evidence that the Pgp-1 glycoprotein is expressed on thymus-homing progenitor cells of the thymus. , 1985, Cellular immunology.
[75] C. Underhill. Interaction of hyaluronate with the surface of simian virus 40-transformed 3T3 cells: aggregation and binding studies. , 1982, Journal of cell science.
[76] J. Woodruff,et al. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules , 1976, The Journal of experimental medicine.
[77] I. Roitt,et al. Encyclopedia of immunology , 1998 .
[78] A. Miyawaki,et al. Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. , 1994, Receptors & channels.
[79] K. Miyake,et al. A new cell adhesion mechanism involving hyaluronate and CD44. , 1990, Current topics in microbiology and immunology.
[80] M. Letarte,et al. A glycoprotein of molecular weight 85,000 on human cells of B-lineage: detection with a family of monoclonal antibodies. , 1985, Molecular immunology.